Skidgel R A, Friedman W F, Printz M P
Pediatr Res. 1984 Jan;18(1):12-8.
Experimental evidence from many laboratories implicates products of arachidonic acid metabolism in perinatal homeostasis of the circulation of the ductus arteriosus. Studies were conducted to define the potential prostaglandin and prostanoid biosynthetic capabilities of the isolated fetal lamb ductus arteriosus, other fetal blood vessels, and isolated fetal and neonatal lung tissue as possible humoral sources of vasoactive products. Because the biosynthetic pathway is a sequential cascade of enzyme reactions, both radiolabeled synthetic endoperoxide (PGH2) and arachidonic acid were used as substrates. Prostacyclin (PGI2) synthase was the primary enzymatic pathway for metabolism of exogenous PGH2 by the isolated ductus arteriosus; no conclusive evidence was found for enzymatic formation of PGE2 or thromboxane A2 (TXA2). The PGI2 synthase activity of the ductus arteriosus was intermediate between arterial tissues (high) and veins (low). A relatively high cyclooxygenase activity was apparent in isolated lung tissue exhibited enzymatic activity for the formation of PGI2, PGE2, and TXA2 from synthetic PGH2. Lung thromboxane synthase activity was markedly elevated late in term due to an apparent increase in Vmax without change in Km, indicative of increased enzyme concentration. Although exogenous PGE2 has been shown to be a more potent relaxant of the ductus arteriosus than PGI2, our study could not positively identify an enzymatic pathway for the total intramural biosynthesis of PGE2. Similarly, no evidence was found for a locally generated constrictor prostanoid, e.g., TXA2. Our results suggest that humoral sources of vasodilator (PGE2 and PGI2) and vasoconstrictor (TXA2) products may be more important than local production in control of the ductus arteriosus and point to the importance of the fetal and neonatal lung in cardiovascular adaptations and homeostasis.
来自许多实验室的实验证据表明,花生四烯酸代谢产物与动脉导管循环的围产期稳态有关。开展了多项研究,以确定分离出的胎羊动脉导管、其他胎儿血管以及分离出的胎儿和新生儿肺组织中潜在的前列腺素和类前列腺素生物合成能力,这些组织可能是血管活性产物的体液来源。由于生物合成途径是一系列酶促反应的级联过程,因此放射性标记的合成内过氧化物(PGH2)和花生四烯酸均被用作底物。前列环素(PGI2)合酶是分离出的动脉导管代谢外源性PGH2的主要酶促途径;未发现PGE2或血栓素A2(TXA2)酶促形成的确凿证据。动脉导管的PGI2合酶活性介于动脉组织(高)和静脉组织(低)之间。在分离出的肺组织中,相对较高的环氧化酶活性明显表现出从合成PGH2形成PGI2、PGE2和TXA2的酶活性。足月后期肺血栓素合酶活性显著升高,这是由于Vmax明显增加而Km不变,表明酶浓度增加。尽管外源性PGE2已被证明是比PGI2更有效的动脉导管舒张剂,但我们的研究无法明确确定PGE2壁内全生物合成的酶促途径。同样,也没有发现局部产生的缩血管类前列腺素(如TXA2)的证据。我们的结果表明,血管舒张剂(PGE2和PGI2)和血管收缩剂(TXA2)产物的体液来源在动脉导管的控制中可能比局部产生更为重要,并指出胎儿和新生儿肺在心血管适应和稳态中的重要性。